Harvard Bioscience, Inc.

Harvard Bioscience, Inc.

Harvard Bioscience, Inc.

Overview
Date Founded

2000

Headquarters

84 OCTOBER HILL ROAD, SUITE 10, HOLLISTON, MA, 017461371

Type of Company

Public

Employees (Worldwide)

547

Industries

Industrial Machinery & Manufacturing
Biotechnology

Company Description

Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Contact Data
Trying to get in touch with decision makers at Harvard Bioscience, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Chief Financial Officer

Vice President & General Manager Physiology, Cell & Molecular Instruments

Vice President & General Manager, Electrophysiology

Executive Vice President-Cellular & Molecular Technologies

Vice President of Sales-Denville Scientific

Vice President & General Manager-DSI

Controller & Head-Investor Relations

Supply Chain Coordinator

Director

Board of Directors

Chairman, President & Chief Executive Officer at Harvard Bioscience, Inc.

Director, President & Chief Executive Officer at Entegris, Inc.

Executive Vice President & Chief Financial Officer at OSI Systems, Inc.

Former Senior Vice President & Chief Commercial Officer at Thermo Fisher Scientific, Inc.

Deputy General Counsel at La-Z-Boy Incorporated

Former Chief Financial Officer, Treasurer & Senior Vice President at RSA Security LLC

Former Interim Chief Executive Officer at Harvard Bioscience, Inc.

Paths to Harvard Bioscience, Inc.
Potential Connections via
Relationship Science
You
Harvard Bioscience, Inc.
Owners & Shareholders
Details Hidden

Engine Capital Management is an activist firm and is included in the SharkWatch50 as one the 50 most prominent activist investors.

Details Hidden

Potomac Capital Management focuses in long/short investments in small/micro-cap stocks with a growth bias. The firm employs fundamental, bottom-up research to select their investments. Potomac Capital Management is an activist firm and is included in the SharkWatch50 as one the 50 most prominent activist investors.

Details Hidden

Fondren Management LP is an American private company located in Houston, TX, also operating in the United States, that provides investment advice. The firm was founded in 2005. Bradley Louis Radoff has been the CEO since then.

Recent Transactions
Details Hidden

Harvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Details Hidden

Thomas Scientific LLC purchases Denville Scientific, Inc. from Harvard Bioscience, Inc.

Details Hidden

Capp ApS purchases AHN Biotechnologie GmbH from Harvard Bioscience, Inc.

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Auditor

Advised onHarvard Bioscience, Inc. issued Common Stock

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Genomic Solutions, Inc.

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Co-Chair, Venture Capital & Private Equity Practice

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Investor Relations Officer

Advised onHarvard Bioscience, Inc. purchases HEKA Elektronik Dr. Schulze GmbH

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Key Stats and Financials As of 2018
Market Capitalization
$105M
Total Enterprise Value
$169M
Earnings Per Share
$-0.11
Revenue
$121M
Total Equity
$82.7M
Net Profit
$-4.17M
EBITDAMargin
7.3%
Enterprise Value Sales
1.4x
Debt TEV
0.36x
TEVNet Income
-40.39x
Enterprise Value EBITDAOperating
19.11x
EBITDA
$8.82M
Total Debt
$60.8M
Five Year Compounded Annual Growth Rate Of Revenue
2.81%
Three Year Compounded Annual Growth Rate Of Revenue
3.58%
Investors
Details Hidden

NEP focuses on investing in companies in the technology, healthcare, and consumer product industries. Within the technology sector, they concentrate on investing in companies in the Internet, software, hardware and communications industries. In healthcare, they target biopharmaceutical, biotechnology, medical device and e-health companies. In consumer products, they seek companies that can offer distinctive products in a mass-market retail channel setting.The firm seeks early and later stage companies that are beyond the concept stage, have demonstrable technology and evidence of product or service acceptance. For companies with greater financial needs, NEP has a history of syndicating with other reputable venture capital or strategic investors. They participate in all stages of a company's equity financing needs, from a first institutional round of equity to a mezzanine round before an IPO.NEP concentrates on investing in companies that target potentially large markets. In addition, they work closely with portfolio companies in setting goals and financial objectives to maximize the overall financial return of the company and its investors.They seek to invest in companies that offer the potential for a relatively early initial public offering or sale to a strategic buyer. They also assist their portfolio companies in achieving liquidity by way of a sale to a financial investor or through a recapitalization.

Details Hidden

Ascent Venture Management Inc. invest in early stage companies based in east coast US, cross Atlantic, Europe and Israel. It invests in Enterprise technology.

Details Hidden

First New England Capital (FNEC) invests in mezzanine and equity securities of middle market, later-stage companies across a variety of industries that have generated $10 million to $150 million of revenue and have demonstrated an ability to deliver strong operating performance and cash flow. They also consider investments in dynamic, fast-growing companies with a demonstrated ability to execute well-defined operating strategies. The firm seeks companies which have demonstrated a balance between sustainable growth and expense control.The firm prefers to invest in transactions that range in size from $2 million to $7 million. They may also make smaller investments in companies that have the potential for follow-on investment or larger investments in combination with other investment partners. Investments may be structured as current pay and/or payment-in-kind securities, preferred stock or common equity in conjunction with mezzanine capital.FNEC's capital is typically used to provide liquidity to founders and existing shareholders, to make acquisitions or finance organic growth. They will act as lead or participate as a member of larger syndicates. FNEC is often a minority investor. In most investments, FNEC requires board representation.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Becton, Dickinson & Co. Medical Products & Equipment - Franklin Lakes, New Jersey

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Harvard Bioscience, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Harvard Bioscience, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Harvard Bioscience, Inc..